Stay updated with breaking news from Patrick Lin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) had its price objective reduced by Oppenheimer from $5.00 to $3.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have an outperform rating on the stock. Oppenheimer also issued estimates for Processa Pharmaceuticals’ Q1 2023 earnings at ($0.28) EPS, Q2 2023 earnings at […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) – Investment analysts at Oppenheimer decreased their Q1 2023 earnings per share (EPS) estimates for shares of Processa Pharmaceuticals in a research report issued on Monday, April 3rd. Oppenheimer analyst F. Brisebois now anticipates that the company will post earnings of ($0.28) per share for the quarter, down […]
The cofounder of Taiwan's famed Din Tai Fung restaurant chain died at 96, his company announced March 26. He helped turn delicate soup dumplings into a global phenomenon, even earning Michelin stars.
The cofounder of Taiwan's famed Din Tai Fung restaurant chain died at 96, his company announced March 26. He helped turn delicate soup dumplings into a global phenomenon, even earning Michelin stars.
The cofounder of Taiwan's famed Din Tai Fung restaurant chain died at 96, his company announced March 26. He helped turn delicate soup dumplings into a global phenomenon, even earning Michelin stars.